Commonwealth Informatics Helps Life Science Companies and Regulatory Agencies Improve Drug Safety

Rhea-AI Summary

Commonwealth Informatics, a subsidiary of Genpact, launched an upgraded version of its Commonwealth Vigilance Workbench (CVW) on March 22, 2021. This cloud-based solution aims to enhance drug safety through advanced AI and analytics, benefiting life sciences and regulatory agencies. Two major global pharmaceutical companies have implemented the new CVW, which streamlines signal detection and management of adverse drug effects. The latest enhancements improve data review, signal tracking, and report generation. Commonwealth's focus on pharmacovigilance is timely, given the ongoing COVID-19 pandemic.

Positive

• Upgraded CVW enhances drug safety through AI and analytics.
• Two major pharmaceutical companies have successfully implemented the current CVW release.
• Improved functionalities include safety data review and signal tracking.

Negative

• None.

WALTHAM, Mass., March 22, 2021 /PRNewswire/ -- Commonwealth Informatics, an independently-operated subsidiary of Genpact, and leading technology and services company with industry expertise in medical product safety and public health surveillance, today announced the latest release of its Commonwealth Vigilance Workbench (CVW), an innovative cloud-based solution that leverages artificial intelligence and advanced analytics to help life sciences companies and government regulatory agencies improve drug safety through end-to-end signal detection and management.

Commonwealth, in collaboration with its clients, which include four of the top ten pharmaceutical companies, is creating the industry standard for signal detection and management to identify drug adverse effects more quickly and efficiently. Two of the largest global pharmaceutical companies have gone live with CVW's current release, which helps generate and assess evidence from individual case safety reports, clinical trial data sets, electronic health records, and other information sources.

"Combatting COVID-19 has underscored the critical need for fast and efficient signal detection and management to improve drug safety, and a cloud-based solution provides agility and ability to scale quickly," said Commonwealth's President Geoff Gordon. "CVW combines valuable input from our early-adopter clients with innovative technology and insights from our development team to enhance the pharmacovigilance process as a whole, which in the end, can help save patients' lives."

With user-friendly dashboards that integrate data across various modules, the latest CVW enhancements improve:

• Planning for safety data review,
• Conducting signal detection, validation, and assessment,
• Tracking signals, risks, and regulatory inquiries, and
• Producing reports for internal and external stakeholder communication.

See Commonwealth Informatics' website for more details.

About Commonwealth Informatics
Commonwealth Informatics is a technology and services company with industry expertise in medical product safety and public health surveillance. Pharmaceutical and biotechnology companies, government agencies, and healthcare providers use Commonwealth's products and services to assemble relevant data and answer complex clinical and safety analysis questions quickly and accurately. Commonwealth is an independently-operated subsidiary of Genpact (NYSE: G), a global professional services firm focused on delivering digital transformation. Learn more about the innovative products and services that are helping to improve the speed and accuracy of pharmacovigilance evidence generation at https://www.commoninf.com.

CONTACT:
Michelle Tully
978-606-7682
mtully@commoninf.com 

View original content:http://www.prnewswire.com/news-releases/commonwealth-informatics-helps-life-science-companies-and-regulatory-agencies-improve-drug-safety-301251149.html

SOURCE Commonwealth Informatics, a Genpact company

FAQ

What is the Commonwealth Vigilance Workbench (CVW)?

The Commonwealth Vigilance Workbench (CVW) is a cloud-based solution developed by Commonwealth Informatics to improve drug safety through signal detection and management.

When was the latest CVW release announced?

The latest release of the Commonwealth Vigilance Workbench was announced on March 22, 2021.

Which companies are using the Commonwealth Vigilance Workbench?

Two of the largest global pharmaceutical companies are currently using the Commonwealth Vigilance Workbench.

What advancements does the latest CVW release include?

The latest CVW release includes enhancements in signal detection, safety data review, and risk tracking.

How does COVID-19 impact the need for improved drug safety solutions?

The COVID-19 pandemic has highlighted the critical need for fast and efficient signal detection and management in drug safety.